No Borders, Inc. (Ticker

NBDR) Has Begun Receiving and Shipping of the 15 Minute COVID-19 Serological Tests in the USA

QUEEN CREEK, AZ, April 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ No Borders, Inc. (OTC:NBDR), today announced that the Company has in the past week received its initial shipment of COVID-19 serological tests into its operations center in Phoenix, Arizona, with the first shipment to a New Jersey municipality being sent out last Wednesday. 

Through our medical supply chains, the Company has been able to import a 15 minute COVID-19 test for distribution. Using a serology test allows patients to see if their body has developed antibodies that could have been created by being infected with the COVID-19 virus. The manufacturers of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit in China have applied for the Emergency use Authorization (“EUA”) registration with the Food and Drug Administration (“FDA”), allowing them to be sold in the United States. 

While the manufacturers of these tests have applied for their respective EUA’s, the FDA has not approved of these tests as of yet. Negative results do not rule out SARS-CoV-2 infection, and positive results may be due to a past or present infection of SARS-CoV2 or a similar coronavirus strain such as HKU1 or NL63 as examples.

In order to assist the Company with these processes, the Company has retained an experienced FDA & import/export legal firm Benjamin L. England & Associates of Washington, D.C., to represent No Borders, Inc., in ongoing FDA and import/export matters. Based on the most recent guidance from the FDA (LINK HERE) and the interpretation of said guidance by said law firm the Company has begun shipments of these tests within the last 7 days. 

These tests that MediDent Supplies is shipping into the USA use what’s called a “serological” technique, which looks for antibodies in a patient’s blood. These are only present if someone has been exposed to the SARS-CoV-2 virus, since, as of right now, researchers haven’t found any evidence that natural antibodies to this particular virus exist without exposure to the virus. By contrast, the types of tests that are currently in use in the USA and at labs around the world are “PCR” tests, which use a molecular-based, batch testing approach to determine if the virus is present genetically in a mucus specimen.